Recent matter
5 February 2025
New Year, New Opportunities: What Changes to Expect in Employment Law in 2025
The year 2025 will be marked by the introduction of new legislative proposals in parliament. We’ll provide a brief overview of these proposals in this update. Proposal to Improve the Stability of Flexible Workers This draft law aims to provide more job security for employees while maintaining flexibility for employers. Key measures include: Finally, the gap in the chain regulation will be extended from six months to five…
Read more >5 February 2025
Changes as of 1 January 2025
With the conclusion of the first month of the new year, it is an opportune time to review several significant changes to employment law and related regulations that took effect on 1 January 2025. End of the Enforcement Moratorium on false self-employment Effective 1 January 2025, the Dutch Tax Authorities will resume standard enforcement measures regarding the misclassification of self-employment. Accordingly, the regular payroll tax rules shall once…
Read more >4 February 2025
The New Originals Company GmbH acquires SoFine Foods
Rutgers & Posch advises The New Originals Company, a leading European tofu producer, in relation to its acquisition of SoFine Foods, a Dutch manufacturer of tofu and soy products, from a subsidiary of the Migros Group. The team of Rutgers & Posch consisted of Lennaert Posch, Laura Dingemans, Laetitia Wezenbeek, Maarten Minnaard, Annemeijne Zwager and Jamie Pellegrom.
Read more >28 January 2025
SICK AG acquires Accerion
Rutgers & Posch advises SICK AG in relation to its acquisition of Accerion, a Dutch provider of positioning systems for mobile robots to be used in warehouses and factory floors. The team of Rutgers & Posch consisted of Matthijs van den Broek, Laura Dingemans and Thomas Been.
Read more >28 January 2025
Rutgers & Posch advises uniQure in public offering
Rutgers & Posch represented NASDAQ listed uniQure N.V. in respect of its $75 million fully underwritten public offering of new ordinary shares. uniQure is advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS, Fabry disease, and other severe diseases. Bas Visée and Jamie Pellegrom advised uniQure. Rutgers & Posch teamed up with US firm Morgan Lewis. For…
Read more >13 December 2024
Ridder announces strategic partnership with Navus CEA Enterprises to drive growth and innovation
Rutgers & Posch advises Ridder, a Dutch global leader in horticulture automation solutions, providing advanced technology and connected smart solutions to growers in over 100 countries, in relation to its strategic partnership with Navus CEA Enterprises, a “spin off” of Navus Ventures, both investment companies belonging to the Lanvi group, as does Lely (Farming innovators). The team of Rutgers & Posch consisted of Matthijs van den Broek, Veerle…
Read more >